Skip to main content

UR Medicine

menu
UR Medicine / UR Medicine Epilepsy Center / Ongoing Clinical Trials

 

Ongoing Clinical Trials

Epilepsy Research at URMC

The University of Rochester Medical Center is a research institution. We participate in research that helps our patients and improves our knowledge. Doctors and staff in our adult and pediatric epilepsy areas are committed to participation in clinical trials. 

What are Clinical Trials?

Clinical trials are research studies that are highly regulated (carefully controlled) by independent groups (not associated with the clinical trial) to make sure that research is done in a safe and ethical way. 

We are looking for patients for the studies listed below.

Epilepsy Clinical Trials at URMC

StarStim: New External Device for Refractory Focal Epilepsy (A Multicenter, Randomized, Double-Blinded, Parallel-Group Study of the Safety and Therapeutic Measures of Transcranial Cathodal Direct Current Stimulation (TDCS) in Patients with Refractory Focal Epilepsy. Protocol Number NE001)

We are looking for patients 9 years and older who have been diagnosed with focal epilepsy for a trial with a new external device that stimulates the brain from outside your scalp.  Dr. Trenton Tollefson is the Principal Investigator on this study.

STARS: Staccato alprazolam for Focal or Generalized Seizures (A Phase 3, Double-blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures. Protocol Number EP0162)

We will be looking for patients between 18 years and older who have been diagnosed with focal or generalized seizures for the Staccato alprazolam trial. Alprazolam is being tested as a rescue medication (a medicine intended to quickly stop repetitive or prolonged seizures). Alprazolam is approved by the FDA in pill form (Xanax) for anxiety and other conditions. Dr. Thomas Wychowski is the Principal Investigator on this study.

Coming Soon!
A randomized controlled trial of a new medication (GV101) for patients with Cerebral Cavernous Malformation.

 

All studies are listed on www.clinicaltrials.gov

If you are a patient and are interested in learning about our research studies, or if you are a CRO or Sponsor and you wish to speak with someone about URMC becoming a site, please email: URMCEpilepsyStudies@URMC.Rochester.edu